Showing results (381-390 of 517) with videos related to

Sort By:
Pageof 52
Pediatric Research|January 26, 2019
Mediators of racial and ethnic disparity in mother's own milk feeding in very low birth weight infantsAloka L Patel, Michael E Schoeny, Rebecca Hoban, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapyStuart Ellison, Aiyin Liao, Hélène F E Gleitz, et al.
The American Journal of Cardiology|January 1, 1988
Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarctionF I Marcus, L A Cobb, J E Edwards, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Plos One|February 8, 2014
Assessment of sleep in children with mucopolysaccharidosis type IIILouise Victoria Mahon, Michelle Lomax, Sheena Grant, et al.
International Journal of Cardiology|January 1, 1983
Desmethylimipramine and imipramine on left ventricular function and the ECG: a randomized crossover designE G Giardina, J T Bigger, A H Glassman, et al.
The American Journal of Cardiology|September 1, 1982
Response to programmed ventricular stimulation: sensitivity, specificity and relation to heart diseaseF D Livelli, J T Bigger, J A Reiffel, et al.
Journal of Neuroinflammation|February 7, 2019
Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumoursA Saam Youshani, Samuel Rowlston, Claire O'Leary, et al.
Genes, Brain, and Behavior|June 4, 2011
Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environmentsA Langford-Smith, M Malinowska, K J Langford-Smith, et al.
Circulation|December 16, 1998
Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch TrialH M Spotnitz, J M Herre, S T Raza, et al.
Pageof 52